PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in head and neck cancers

被引:0
|
作者
Patil, Revati [1 ]
Akolkar, Dadasaheb B. [1 ]
Patil, Darshana [1 ]
Devhare, Pradip [1 ]
Srivastava, Navin [1 ]
Fulmali, Pooja [1 ]
Patel, Shoeb [1 ]
Shejwalkar, Pradyumna [1 ]
Datta, Vineet [1 ]
Sims, Cynthe [1 ]
Srinivasan, Ajay [1 ]
Datar, Rajan [1 ]
机构
[1] Datar Canc Genet Ltd, Nasik, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
36
引用
收藏
页数:1
相关论文
共 50 条
  • [1] PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in gastroesophageal cancers
    Devhare, Pradip
    Patil, Revati
    Akolkar, Dadasaheb B.
    Patil, Darshana
    Srivastava, Navin
    Fulmali, Pooja
    Patel, Shoeb
    Shejwalkar, Pradyumna
    Datta, Vineet
    Sims, Cynthe
    Srinivasan, Ajay
    Datar, Rajan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [2] PD-L1 expressing circulating tumour cells in head and neck cancers
    Kulasinghe, Arutha
    Perry, Chris
    Kenny, Liz
    Warkiani, Majid E.
    Nelson, Colleen
    Punyadeera, Chamindie
    BMC CANCER, 2017, 17
  • [3] PD-L1 expressing circulating tumour cells in head and neck cancers
    Arutha Kulasinghe
    Chris Perry
    Liz Kenny
    Majid E. Warkiani
    Colleen Nelson
    Chamindie Punyadeera
    BMC Cancer, 17
  • [4] Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker
    Oualla, Karima
    Castelo Branco, Luis
    Nouiyakh, Lamiae
    Amaadour, Lamiae
    Benbrahim, Zineb
    Arifi, Samia
    Mellas, Nawfel
    CANCER CONTROL, 2021, 28
  • [5] PD-L1 profiling of circulating tumour cells is a viable companion diagnostic for checkpoint inhibitor therapy in lung cancer
    Patil, R.
    Limaye, S.
    Akolkar, D.
    Patil, D.
    Datta, V.
    Devhare, P.
    Patel, S.
    Srinivasan, A.
    Datar, R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [6] Circulating tumour cell PD-L1 test for head and neck cancers
    Kulasinghe, Arutha
    Kenny, Liz
    Punyadeera, Chamindie
    ORAL ONCOLOGY, 2017, 75 : 6 - 7
  • [7] Radiotherapy Sensitizes Head and Neck Tumors to PD-L1 Immune Checkpoint Blockade
    Oweida, A. J.
    Calame, D.
    Lennon, S.
    Bhatia, S.
    Raben, D.
    Clambey, E.
    Heasley, L.
    Nemenoff, R.
    Karam, S. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S202 - S202
  • [8] Acral Necrosis After PD-L1 Immune Checkpoint Inhibitor Therapy
    Logan, Sam
    Shinohara, Michi M.
    CUTIS, 2023, 111 (05): : E16 - E17
  • [9] Immune Checkpoint Therapy in Head and Neck Cancers
    Msaouel, Pavlos
    Massarelli, Erminia
    CANCER JOURNAL, 2016, 22 (02): : 108 - 116
  • [10] Simultaneous quantification of activated immune cells and PD-L1 expressing circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy
    Krupa, Rachel
    Richardson, Robin
    Ontiveros, Priscilla
    Schonhoft, Joseph
    Byun, Jiyun
    Lu, David
    Nisperos, Sean
    Wang, Yipeng
    Landers, Mark
    Dittamore, Ryan
    CANCER RESEARCH, 2019, 79 (13)